KalVista Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein …

Biotechnology
US, Cambridge [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of KALV's Analysis
CIK: 1348911 CUSIP: 483497103 ISIN: US4834971032 LEI: - UEI: -
Secondary Listings
KALV has no secondary listings inside our databases.